|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02410 TYK MEDICINES-B
Nominal 
6.810 -0.290 (-4.085%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 0 | -- | 0 | 107 | 0 | 44,242 |
| Cost of Sales | -- | -- | -- | (93) | -- | (24,199) |
| Gross Profit | -- | -- | -- | 14 | -- | 20,043 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | (60,758) | (77,790) | (69,112) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (3,834) | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (26,882) | -76.433% | (305,972) | (387,928) | (383,171) | (311,802) | |
| Taxation | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 1,985 | 5.138% | 6,204 | 973 | 744 | 809 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (24,897) | -77.806% | (299,768) | (386,955) | (382,427) | (310,993) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 7,101 | 8.429% | 12,889 | 10,800 | 21,536 | 13,483 |
| Depreciation & Amortisation | 10,388 | -18.082% | 25,020 | 29,324 | 27,642 | 16,329 |
| Directors' Emoluments | -- | -- | -- | 9,087 | 3,779 | 2,775 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -7.000 | -76.667% | -80.000 | -115.000 | -132.000 | -- |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.576) | (0.913) | (0.696) | -- |
| NBV per share ($) | 0.687 | -- | 0.754 | 1.265 | -- | -- |
| Remarks: | Real time quote last updated: 19/08/2026 15:38 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -24,897 |
| %Change | -77.806% |
| EPS / (LPS) | RMB -0.070 |
| NBV Per Share (¥) | RMB 0.687 |